Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197
Original registry description
This is a randomised, double-blind, parallel group, placebo-controlled Phase IIa study designed to evaluate the efficacy and safety of AZD7798 in participants with moderate to severe Crohn's disease.